Cours international

6th European Course of in vivo Preclinical Assays in Cancer Therapy

In vivo Preclinical Models in cancer

The 6th European Course of in vivo Preclinical Assays in Cancer Therapy is an extensive training program designed to educate and update the biomedical research community on current trends and technological advances in in vivo preclinical assays in cancer.
The emphasis of this course will be on the use of genetically engineered mouse models and patient-derived xenograft (PDX) models for in vivo preclinical research.
The course will cover the following topics: in vitro preclinical assays employing established tumor cell lines and functional genomics approaches, preclinical imaging, angiogenesis and metastasis, Zebrafish model, therapy resistance models and approaches, ethics and co-clinical trials.

Organizers: Virginie Dangles-Marie, Elisabetta Marangoni, Jos Jonkers (NKI), Sven Rottenberg (NKI)

Registration (form and steps below)

The course will be open to European PhD, post-docs and confirmed researchers from private and academic research. Lectures will be held in English.

The number of participants will be restricted to 80 to promote exchange between participants and speakers. Registration will be done on the basis of 1st come-1st served and validated only AFTER reception of the purchase order or payment.

May 21 - 23, 2014
28 April 2014

Institut Curie
Amphithéâtre Constant-Burg
12 rue Lhomond, 75005 Paris

Academic : 300€ TVA incluse
Industry : 450€ TVA incluse
(coffee breaks, lunches and social dinner on Thursday evening included)

Virginie Dangles-Marie (Institut Curie), Jos Jonkers (NKI), Elisabetta Marangoni (Institut Curie), Sven Rottenberg (NKI)

NKI
Faculté des Sciences Pharmaceutiques et Biologiques Paris Descartes

Ligue Nationale contre le Cancer
Cancéropole Ile de France